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SALIVARY ALPHA-AMYLASE REACTIVITY DURING DISCUSSION OF THE 
DEATH OF A SPOUSE IN RECENTLY BEREAVED ELDERS 
 
EDWARD KING 
ABSTRACT 
In this study, bereavement-related biological and physiological stress reactivity 
during the discussion of a loss are evaluated by collecting saliva samples in patients aged 
55 or more who have lost a spouse within the last 12 months.  The concentration of 
salivary α-Amylase, a marker for stress, is measured. Grief symptoms are also examined 
in these individuals.   
Background 
Grief is a complex psychobiological phenomenon triggered by the loss of a loved 
one, and that comprises emotions (e.g., yearning, longing, intense feeling of 
sorrow/emotional pain), thoughts (e.g., thoughts or images about the deceased, difficulty 
accepting the death, guilt), and behaviors (e.g., avoidance of reminders, spending time 
with deceased belonging).  Because bereavement is a major stressor, it has been 
suggested that the grief reaction is associated with increased sympathetic activity.  
Salivary α-Amylase levels have been proposed to be a reliable non invasive biomarker of 
sympathetic activity.  The present study aims to examine salivary α-Amylase reactivity to 
discussion of the death of a spouse in older adults, and the relationship between this 
reactivity and grief symptom severity. 
Methods 
  vi 
Participants were N=8 individuals who have lost a spouse within the last year 
(Mean(SD)age=72.8(7.5); 60% women); Mean(SD) time since death=10.6(2.5) months).  
Participants completed self-reported measures including the 19-item Inventory of 
Complicated Grief (ICG; total score ranges 0-76; Prigerson et al. 1995).  The Mean(SD) 
ICG score was 30.5(11.5).  Saliva samples were collected using cotton swabs and 
Salivettes at four time points during the screen: right before discussion of the loss (T1), 
right after discussion of the loss (T2), before screening for psychiatric disorders (T3), and 
at the end of the screening (T4). Salivary α-Amylase samples were frozen and assayed 
using a kinetic enzyme assay kit specifically designed and validated for the kinetic 
measurement of salivary α-Amylase activity.  A repeated measure ANOVA, with α-
Amylase as the dependent variable, and time as the within subject repeated factor were 
conducted to examine differences in α-Amylase activity across time points.  Further, we 
examined the association between rise in α-Amylase activity (change between T1 and 
T2) and ICG scores.   
Results 
The ANOVA revealed a marginally significant main effect of time (F(3,20)=2.74, 
p=0.07), with α-Amylase activity being more elevated right after discussion of the loss 
(T2; Mean (SD)=194.9(79.4) µg/dL) compared to the other time points (T1: 140.00(77) 
µg/dL; T3: 140.5(56) µg/dL; T4: 143.0(70.3) µg/dL).  Further, the rise in α-Amylase 
activity between T1 and T2, was marginally significantly associated with greater grief 
symptoms (r=0.69, p=0.08).  
Conclusion 
  vii 
Our preliminary findings suggest that discussion of the loss of a spouse may 
increase salivary α-Amylase activity, reflecting a potential increase in sympathetic 
activity.  Targeting loss-related sympathetic reactivity might be an interesting avenue to 
decrease grief related distress and impairment.  Limitations for this study include a small 
sample size and the absence of a real control condition.  Future research examining 
sympathetic activity in grief and its relationship with persistent complex bereavement 
disorder pathophysiology is warranted.   
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INTRODUCTION 
 
Types of Grief and Symptoms 
Death is an inevitable natural phenomenon.  Different cultures throughout time 
have unique perspectives and ideations about death.  However, a universal challenge is 
coping with the death of a loved one such as a family member, relative, or close friend, as 
this can be one of the most painful events to experience.  Often times, grief can have a 
significant negative effect on the daily life and routines of individuals.  Grief is a 
complex psychobiological phenomenon (LeBlanc, 2016) triggered by the loss of a loved 
one, comprising of complex emotions (e.g., yearning, longing, intense feeling of 
sorrow/emotional pain), thoughts (e.g., thoughts or images about the deceased, difficulty 
accepting the death, guilt), and behaviors (e.g., avoidance of reminders, spending time 
with deceased belonging).  For most individuals, the intensity of the grief will subside in 
the following weeks or months and they will be able to return to their daily routines and 
normal functions.  However, some individuals may experience a more severe case of 
grief called Persistent Complex Bereavement Disorder (PCBD) also known as 
Complicated Grief (CG) or Prolonged Grief Disorder (PGD).  This disorder is listed in 
the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) as a subtype of 
“Other Specified Trauma-and Stressor-Related Disorders” with explicit criteria listed 
under “Conditions for Further Study.”  Complicated Grief is a form of prolonged (more 
than six months) (Robinaugh, 2014) grief reaction that increases suicidality (Latham and 
Prigerson 2004) and morbidity (Prigerson et al. 1997) among survivors adding a major 
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health burden to society and to the millions of individuals who suffer from it.  Recent 
research conducted on Complicated Grief has reported that loss-related emotional pain 
and loss-related yearning were the hallmark features of the grief reaction (Bui et al, 
2015).  About 7% of bereaved individuals will experience Complicated Grief with 
marked distress and functional impairment for years after the death (Kersting et al, 2011).  
Symptoms have shown to be associated with lower quality of life, significant sleep 
disruption, negative health consequences, and suicidal ideation (Marques et al, 2013).   
Stress 
Stress is the process through which environmental demands tax or exceed the 
adaptive capacity of an organism, resulting in distress (Park et al. 2013).  Stress may 
manifest as psychological and/or biological changes that place individuals at risk for 
disease such as heart diseases and diabetes (McEwen, 1998).  Common life stressors 
include work, education, marriage, and finance.  When considering the stress that 
individuals feel when a spouse passes, the premise dates back to evolutionary times.  
Humans have learned that bonding with others and being surrounded by others allowed 
for a higher chance for survival as individuals helped one another in different crucial 
tasks including gathering food and protecting one another from dangers (Brown et al. 
2009).  It has been wired in our biology that losing a spouse threatens our safety and 
causes us to fear for our own survival (Bowlby, 1969).  Because we feel that we are in 
danger, our bodies react accordingly to protect ourselves or to keep us safe which triggers 
our stress response (Shear & Shair, 2005) as shown in Figure 1.  However, loss is not 
something that we can protect ourselves from or something that we can escape.  Even 
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though our brains have triggered us to take action, we cannot undo a loss.  This leads to 
an immense amount of stress on the body.  Because bereavement is a major stressor, it 
has been suggested that the grief reaction is associated with increased sympathetic 
activity (O’Connor et al, 2007).   
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FIGURE 1.  
Stress Response and Relaxation Response. 
HPA Axis that demonstrates how a stress response or relaxation response occurs 
in the body. The hypothalamus, a part of the limbic system that supports functions 
including emotion and behavior, links the nervous system to the endocrine system 
through the pituitary gland.  Once the hypothalamus is stimulated, it synthesizes 
and secretes releasing hormones which stimulate or inhibit the secretion of 
pituitary hormones by the pituitary gland.  The increase of pituitary hormones or 
decrease of pituitary hormones has a direct effect on the hormones secreted by the 
adrenal gland which consist of the adrenal cortex and adrenal medulla.  The 
increase or decrease in hormones produced by the adrenal gland has a direct effect 
on the function of different body organs such as oxygen consumption, blood 
pressure, and heart rate, that are associated with a stress response or relaxation 
response.   
A change in sympathetic nervous system activity can also have a direct effect on 
the adrenal medulla and the norepinephrine that the adrenal medulla produces. 
Dusek and Benson (2009) Minnesota Medicine. 
 
Nervous System 
The physiological effects due to stress are controlled by the nervous system.  The 
nervous system coordinates the voluntary and involuntary actions and transmits signals to 
and from different parts of the body.  Two components of the nervous system are the 
parasympathetic nervous system (PNS) and sympathetic nervous systems (SNS) which 
work together to maintain homeostasis (Pocock, 2006).  The parasympathetic system 
conserves energy as it slows the heart rate, increases intestinal and gland activity, and 
relaxes sphincter muscles in the gastrointestinal tract.  It is known as the rest-and-digest 
response (McCorry, 2007).  The sympathetic nervous system is complementary to the 
parasympathetic nervous system and stimulates activities associated with the fight-or-
flight response (Cannon, 1932).   The effects of the sympathetic nervous system and 
parasympathetic nervous system on different organs are shown in Figure 2.  
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Figure 2.  
Diagrammatic illustration of the role of the two arms of the autonomic 
nervous system. 
The effects of the sympathetic nervous system and parasympathetic nervous 
system are shown.  In general, the two branches of the nervous system have 
opposite effects on organ functions.   
Vinik (2012) Frontiers in Endocrinology.  
 
 
Types of Neurons in the Sympathetic Nervous System 
There are two neurons in the sympathetic nervous system: the pre-ganglionic and 
post-ganglionic.  The shorter pre-ganglionic neuron travels to the ganglion that synapses 
with the post-ganglionic neuron.  Pre-ganglionic neurons release the neurotransmitter 
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acetylcholine that activates nicotinic acetylcholine receptors on post-ganglionic neurons.  
Once activated, a majority of post-ganglionic neurons release the catecholamine 
norepinephrine which activates adrenergic receptors on peripheral target tissues as shown 
in Figure 3.  This activation leads to the physiological effects associated with the 
sympathetic nervous system (Drake et al. 2015).   
 
Figure 3. 
Pre-ganglionic and Post-ganglionic neurons. 
The pre-ganglionic neuron originates in the brainstem or the spinal cord and is 
shorter in the sympathetic nervous system than the parasympathetic system.  Both 
pre-ganglionic neurons release acetylcholine which activates the ganglion cells, or 
post-ganglionic neurons which lies outside of the central nervous system.  The 
post-ganglionic neuron release acetylcholine which effects cardiac muscle, 
smooth muscle, and glands.  Post-ganglionic neurons in the sympathetic nervous 
system can release either acetylcholine or norepinephrine which effect the effector 
organs.   
(2017) Michigan State University College.   
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Salivary α-Amylase 
One of the stimulatory effects of the sympathetic nervous system is the release of 
the salivary enzyme, α-Amylase (Nater et al. 2009) shown in Figure 4.  Salivary α-
Amylase, also known as 1,4-α-D-Glucan glucanohydrolase, is a protein enzyme that 
hydrolyzes alpha bonds of large, alpha-linked polysaccharides such as starch and 
glycogen into the monosaccharide glucose, and disaccharide maltose (Schenkels et al. 
1995).   
 
Figure 4. 
Salivary α-Amylase molecule 
A 3-dimensional picture of the enzyme molecule that hydrolyses alpha bonds of  
large, alpha-linked polysaccharides, such as starch and glycogen into glucose and 
maltose.  It is the major form of amylase found in humans and other mammals.   
(2017) Salimetrics. 
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Glucose and Maltose both have free aldehyde groups and have the ability to form 
strong hydrogen bonds with sweet taste receptors which activate the receptors and allow 
us to taste sweetness (Temussi, 2007) shown in Figure 5.   
 
 
Figure 5. 
Sugar Molecule Binding To Receptor. 
The sugar molecule forms different bonds with the sweet receptor including 
hydrogen bonds, dipole bonds and non-polar bonds.  These receptors are found in 
the circumvallate papillae and the foliate papillae near the back of the tongue and 
the roof of the mouth.  Once the sugar molecule binds to the receptor and the 
receptor is activated, the cell synapses with the chorda tympani and 
glossopharyngeal nerves to send signals to the brain that a sweet substance is 
being consumed. 
(2017) Unilever Education. 
 
Salivary α-Amylase has a daily secretion pattern of a sharp decrease in the first 
hour after awakening followed by an increase throughout the day.  Momentary stress are 
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relatively independent to diurnal salivary α-Amylase but chronic stress and mood is 
significantly associated (Nater et al., 2007).  Alpha-Amylase has been shown to be 
released by acinar cells in the salivary gland when activated by the autonomic 
sympathetic nervous system (Nater et al, 2006).  It is not controlled by the activity of the 
limbic hypothalamic-pituitary-adrenal (HPA) axis such as the glucocorticoid, cortisol 
(Nater et al. 2009).  The HPA axis, a major neuroendocrine system that controls reactions 
to stress is another method to evaluate a stress response (Bellavance & Rivest, 2014).  
However, α-Amylase has a quicker response to a stress stimuli and α-Amylase is a non-
invasive marker (Thoma et al, 2012) as it is present in saliva whereas cortisol is present 
in blood.  Alpha-Amylase concentrations are predictive of plasma catecholamine levels, 
particularly norepinephrine, under stressful conditions (Chatterton Jr et al, 1996).  Alpha-
Amylase is an important and accurate non-invasive marker for both physical and 
psychological stress (Thoma et al, 2012).   
Summary 
Data suggest that bereavement is a stressor that will elicit a stress response in 
individuals.  The stress response may be triggered by reminders of the death and can be 
measured by salivary α-Amylase.  However, the mechanism behind being reminded of 
the death generating a stress response remains unclear.  Studies have suggested that grief-
related panic symptoms may be prevalent among grieving individuals (Bui et al, 2014) 
indicating that thoughts about the death may trigger the activation of the sympathetic 
system.  Being able to confirm this may lead to a better understanding of the grieving 
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process in recently bereaved elders and the possibility of finding more effective 
treatments for grieving individuals. 
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AIMS/OBJECTIVES 
 
The purpose of this study is to examine the sympathetic reactivity during 
reminder of the recently bereaved subject’s loss by examining the quantity of salivary α-
Amylase produced by subjects during the discussion of the loss of a spouse.  The 
magnitude of reactivity associated with grief symptom severity is also assessed and the 
association between salivary α-Amylase reactivity to discussion of loss and grief 
symptom severity is examined.  
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METHODS 
 
Participants 
 
Bereaved adults were recruited through advertisement and referral.  Inclusion 
criteria included male or female outpatients 55 years of age or greater, widowed (spouse 
or partner) in the past year; bereavement-related distress defined by CGI-S scale greater 
than three regardless of presence of psychiatric diagnosis; being psychotropic medication 
free for more than two weeks or on a stable dose for more than six weeks prior to 
baseline; and willing to comply with study protocol and ability to participate in the 
intervention.  Exclusion criteria included inability to understand study procedures or to 
provide informed consent; serious medical illness or instability likely requiring 
hospitalization within 6 months; current active suicidal ideation; lifetime history of 
psychotic disorder; alcohol or substance abuse or dependence within the past six months; 
practice of yoga, meditation, guided imagery or other mind-body techniques eliciting the 
Relaxation Response (Figure 1), once per week for 45 minutes or more within past three 
months; current medical condition that would preclude safe and effective practice of the 
intervention.  Inclusion and Exclusion Criteria are shown in Table 1.   
Table 1. Inclusion / Exclusion Criteria (Widowed 
Participants) 
 
Inclusion Criteria  Rationale 
Male or female outpatients aged ≥55, widowed (spouse or 
partner) in the past year 
Population 
studied 
Clinically significant bereavement-related distress defined by 
CGI-S scale ≥ 3 regardless of presence of psychiatric 
diagnosis* 
Population 
studied 
Psychotropic medication free (≥2 wks) or stable dose (≥6 wks) 
prior to baseline   
Confound 
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Willingness to comply with study protocol and ability to 
participate in the intervention 
Ethical 
concern, 
Feasibility 
Exclusion Criteria Rationale 
Inability to understand study procedures or to provide informed 
consent 
Ethical 
concern 
Serious medical illness or instability likely requiring 
hospitalization within 6 months 
Feasibility, 
safety 
Current active suicidal ideation (assessed with item 12 of the 
QIDS) 
Safety 
Lifetime history of schizophrenia, bipolar disorder, or other 
psychotic disorder  
Confound 
Alcohol/substance abuse or dependence within the past 6 
months  
Confound 
Practice of yoga, meditation, guided imagery or other mind-
body techniques eliciting the RR, once per week for 45 min or 
more within past 3 months 
Confound 
Current medical condition that would preclude safe and 
effective practice of the intervention (physical injuries and 
musculoskeletal problems)  
Ethical 
concern, 
safety 
*Note: Using a multidimensional approach, we will not require any specific 
diagnosis, similar to an ongoing study (R01MH101486). Further, somatic 
complaints will be factored into the CGI-S. 
 
Data collection 
Psychopathological measures (shown in appendix) were evaluated by the 
Structured Clinical Interview (SCID) and the Structured Clinical Interview for 
Complicated Grief (SCI-CG) (Bui et al, 2015).  The SCID is used to make major DSM-5 
Axis I disorder diagnoses.  A SCID summary is included in the appendix.  The SCI-CG is 
a 31-item clinician-administered instrument to assess specifically Complicated Grief 
symptoms.  Score ranges from 31-84 with higher scores indicating higher symptom 
severity.  Participants completed self-reported measures including the 19-item Inventory 
of Complicated Grief (ICG) (Prigerson et al, 1995) which measures pathological grief 
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concerning the subject’s bereavement-related thoughts and behaviors.  Scores range from 
0 to 76 in which higher scores indicated higher grief symptom severity.   
Saliva was collected with salivettes at four different time points; before the 
discussion of the loss, right after the discussion of the loss, before screening of 
psychiatric disorders, and at the end of the screen.  This allowed for the comparison of α-
Amylase concentrations during discussion of the loss to neutral situations.  Saliva 
samples were sent to Salimetrics to have salivary α-Amylase quantitatively measured.  
Procedures 
Patients were contacted and invited through an IRB-approved recontact list that 
included bereaved participants from prior studies conducted by the Center for Anxiety 
and Traumatic Stress Disorders and Complicated Grief Program.  Additional participants 
were self-referred, recruited online, or through IRB-approved advertisements on public 
transportation, or locations throughout the surrounding area.  Patients were reminded the 
day before the visit not to have alcohol or nicotine for 12 hours before the visit, food or 
exercise for two hours before the visit, and anything to drink an hour before the visit.  
Once patients arrive, they first provide signed consent and participate in the screening in 
which the psychiatrist determines if they qualify for a larger IRB-approved study aiming 
to evaluate the effect of Stress Management and Resiliency Training: A Relaxation 
Response Resiliency Program on grief.  If eligible for the study, personal scripts are 
created from each individual’s experience.  Saliva samples were collected using cotton 
swabs and Salivettes.  Patients were instructed to keep the swab in place for 2 minutes 
under the tongue.  Saliva Sample 1 was collected right before discussion of the loss (T1).  
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Saliva Sample 2 was collected right after discussion of the loss (T2).  Saliva Sample 3 
was collected before screening for psychiatric disorders (T3).  Saliva Sample 4 was 
collected at the end of the screening (T4) (Figure 6).  The average time between when 
Sample 1 and Sample 2 were taken was 28 minutes with a standard deviation of 5.3.  The 
average time between Sample 2 and Sample 3 was 14 minutes with a standard deviation 
of 1.2.  The average time between Sample 3 and Sample 4 was 28 minutes with a 
standard deviation of 6.3. 
Patients complete the ICG and Quick Inventory of Depressive Symptomatology 
Questionnaires after meeting with the physician.  Saliva samples were centrifuged 
(3000rpm for 15 min) with supernatant pipetted into tubes and frozen at -70°C until 
processing.  Salivary α-Amylase was assayed using a commercially available kinetic 
reaction assay (Salimetrics, State College, PA).   
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Figure 6. Saliva Sample Collection timeline 
Saliva Sample 1 was collected after the consent form was filled out right before 
discussion of the death.  Saliva Sample 2 was collected after discussion of the death.  
Saliva Sample 3 was collected after the Structured Clinical Interview for Complicated 
Grief was complete.  Saliva Sample 4 was collected after the Structured Clinical 
Interview in which subjects were screened for psychiatric disorders.  
α-Amylase Assay 
A kinetic enzyme assay kit specifically designed and validated for the kinetic 
measurement of salivary α-Amylase activity was used.  A chromogenic substrate, 2-
choro-p-nitrophenol linked with maltotriose is added to α-Amylase and the reaction 
produces 2-chloro-p-nitropheniol which can be spectrophotometrically measured at 405 
nm.   
Data analyses 
A repeated measure ANOVA, with α-Amylase as the dependent variable, and 
time as the within subject repeated factor was conducted to examine differences in α-
Consent Death Discussion SCI-CG SCID part 1 SCID part 2  
#1 #2 #3 #4 
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Amylase across time points to determine if α-Amylase levels increase during discussion 
of a loss.    
The association between the variables, rise in α-Amylase activity (change 
between T1 and T2) which allowed α-Amylase levels to be compared during discussion 
of the loss to baseline level, and ICG scores which reflect grief symptom severity was 
evaluated.   This determined if there was a significant correlation between grief symptom 
severity and change in α-Amylase levels during discussion of the loss.   
Further, the Area Under the Curve of α-Amylase with respect to increase was 
calculated from the equation shown in Figure 7.   
 
 
 
Figure 7. Area Under the Curve with respect to increase equation 
Formula used to calculate the Area Under the Curve with respect to increase.  mi denotes 
the single measurements, ti denotes the time distance between the measurements, 
and n denotes the total amount of measurements. 
(2003) Pruessner et al. 
 
The Area Under the Curve can be used to estimate changes of secretion over a 
specific time period (Pruessner, 2003).  The association between Area Under the Curve 
and ICG scores was analyzed as an alternate method to evaluate the correlation between 
grief symptom severity and change in α-Amylase levels during discussion of the loss.   
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All analyses were conducted using Stata version 12, and the level of statistical 
significance was set to 0.05 (two-tailed). 
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RESULTS 
 
The basic descriptive statistics of the sample is shown in Table 1.  The mean age 
was 72.8 with a standard deviation of 7.5 years.  The age range was from 63 to 86.  60% 
of the subjects were female in the study.  The mean ICG Score was 30.5 with a standard 
deviation of 11.5.  ICG scores ranged from 12 to 45.  The average time since death was 
10.6 months with a standard deviation of 2.5.  The range for average time since death was 
7.1 months to 12.7 months.  The causes of the deaths included cancer, heart diseases, and 
Amyotrophic lateral sclerosis.   
 
Table 2. Demographics of n=8 Individuals with Complicated Grief 
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Salivary α-Amylase Reactivity During Discussion of Loss 
  
Examination of Salivary α-Amylase levels at different time points showed a 
change in enzyme quantity.  Alpha-Amylase activity was more elevated right after 
discussion of the loss (T2; Mean (SD)=194.9(79.4) µg/dL) compared to the other time 
points (T1: 140.00(77) µg/dL; T3: 140.5(56) µg/dL; T4: 143.0(70.3) µg/dL).  This 
elevation in enzyme production by the subjects suggest that they experience stress 
responses while discussing the loss of their loved ones.  The ANOVA revealed a 
marginally significant main effect of time (F(3,20)=2.74, p=0.07).  Alpha-Amylase 
quantities decreases back to around baseline level (T1) at T3 after subjects complete the 
Structured Clinical Interview for Complicated Grief and remains stable while subjects 
were being screened for psychiatric disorders (T4).  This decrease in α-Amylase level 
suggest that there was no longer a stress response once the subjects started discussing 
matter not pertaining to the loss.  The results of α-Amylase levels at different time points 
are shown in Figure 8.   
The range of α-Amylase levels at T1 is from 12 µg/dL to 217.1 µg/dL.  The range 
at T2 is from 50.8 µg/dL to 312.9 µg/dL.  The range at T3 is from 31.5 µg/dL to 214.2 
µg/dL.  The range at T4 is from 48.9 µg/dL to 270.8 µg/dL.  These ranges show that the 
quantity of α-Amylase produced by each individual varies greatly.   
The average time between when Sample 1 and Sample 2 were taken was 28 
minutes with a standard deviation of 5.3.  The average time between Sample 2 and 
Sample 3 was 14 minutes with a standard deviation of 1.2.  The average time between 
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Sample 3 and Sample 4 was 28 minutes with a standard deviation of 6.3.  Different 
subjects had his or her saliva samples collected at different times during the day. 
 
 
 
Figure 8. Quantity of salivary α-Amylase at the 4 different time points graph 
The average enzyme concentration at each time point is shown measured in µg/dL at 
each timepoint.  Time #1 is right before discussing the loss.  Time #2 is right after 
discussing the loss.  Time #3 is before the screen for psychiatric disorders.  Time #4 is at 
the end of the screen.  Also displayed are standard deviation bars that show both 1 
standard deviation above and below the averages.   
 
 
 
 
 
 
140.0 
194.9 
140.5 143.0 
0.0
50.0
100.0
150.0
200.0
250.0
300.0
time #1 time #2 time #3 time #4
Salivary α-Amylase over time (n=8) 
Main Effect of Time 
F(3,20)=2.74,P=0.07 
 µg/dL 
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Correlation Between Change of Salivary α-Amylase During Discussion of Loss and Grief Symptom Severity  
Next, the two variables, change in α-Amylase between T1 and T2 and grief 
symptom severity measured by the Inventory of Complicated (ICG) score were examined 
to determine if subjects experiencing greater grief symptoms had greater increases in α-
Amylase levels while discussing their loss.  The ICG’s reliability in assessing grief 
symptoms in individuals is evident by the high internal consistency and test-retest 
reliabilities.  Individuals with ICG scores greater than 25 were significantly more 
impaired in social, general, mental, and physical health functioning and pain than those 
with scores below 25 (Prigerson et al, 1995).  The average ICG score was 30.5 with a 
standard deviation of 11.5 which means that most subjects were experiencing more 
severe grief symptoms.  The lowest ICG score was 12 and the highest ICG score was 45.  
The smallest change in α-Amylase between T1 and T2 was -34.1 µg/dL and the greatest 
change in α-Amylase between T1 and T2 was 115.1 µg/dL.  Obtaining a negative value 
for the change in α-Amylase between T1 and T2 was interesting as this suggest that this 
particular subject did not have a stress response while discussing the loss.  The rise in α-
Amylase activity between T1 and T2 was marginally significantly associated with greater 
grief symptoms (r=0.69, p=0.08). 
 
 
 
 
 
 
 
 
 23 
 
Figure 9. Change in α-Amylase between T1 and T2 and ICG Score graph 
The change in α-Amylase between T1 and T2 shown measured in µg/dL.  ICG scores 
showing grief symptom severity are recorded with the lowest possible score being 0 and 
the highest possible score being 76.   
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Alternative Correlation Between Change of Salivary α-Amylase During Discussion of Loss and Grief Symptom Severity 
The correlation between the Area Under Curve and ICG score was examined as 
an alternative method to investigate the correlation between Change of Salivary α-
Amylase during discussion of the loss and grief symptom severity.  The Area Under 
Curve variable was used because it is related to the sensitivity of the system, pronouncing 
changes over time (Pruessner, 2003).  The Area Under Curve reflects both the intensity 
and the duration of the stress response.  The Area Under Curve with respect to the 
increase is calculated with reference to the first value instead of the distance from zero 
for all measurements (Pruessner et al, 2003).  The average Area Under Curve value was 
60.3 with a standard deviation of 60.2.  The lowest Area Under Curve value was -59.95 
and the highest Area Under Curve value was 168.  Obtaining a negative value for the 
Area Under Curve was interesting as this suggest that this particular subject did not have 
a stress response while discussing the loss.  The average ICG score was 30.5 with a 
standard deviation of 11.5 which means that most subjects were experiencing more 
severe grief symptoms.  The lowest ICG score was 12 and the highest ICG score was 45.  
The Area Under Curve with respect to increase and ICG Score was not significant.    
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Figure 10. Area Under Curve with respect to increase and ICG Score graph 
Area Under Curve with respect to increase shows the intensity and duration of the change 
in α-Amylase.  ICG scores show grief symptom severity with the lowest possible score 
being 0 and the highest score being 76.    
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DISCUSSION 
 
Preliminary findings suggest that discussion of the loss of a spouse may increase 
salivary α-Amylase activity, reflecting a potential increase in sympathetic activity.  While 
subjects answered the SCID screening questions and the SCI-CG cover sheet questions, 
both of which required subjects to discuss the memory and moment of the death, salivary 
α-Amylase concentrations on average increased.  This demonstrates the physiological 
manifestations of a psychological state and shows that there was a stress response and an 
increase in sympathetic activity during the discussion of the death.  While subjects 
answered SCI-CG and SCID questions, enzyme levels gradually decreased back to 
baseline level as expected.  This means that the subjects’ sympathetic activity decreased. 
The increase in concentration of α-Amylase was also greater in individuals that had 
greater grief symptoms, as reflected by their ICG Score.  This suggests that the more 
grief one is experiencing, the more stressed they become, which results in higher 
sympathetic activity.  However, this could not be confirmed by the results obtained when 
examining the correlation between Area Under Curve with respect to increase and ICG 
score as those results were non significant.   
Studies have also demonstrated that the sympathetic nervous system is chronically 
activated in individuals with Posttraumatic Stress Disorder (PTSD).  In one study, saliva 
samples were collected from sexually abused adolescent girls and compared with the 
saliva samples from healthy subjects.  Results showed total PTSD symptoms and severity 
were associated with higher overall morning levels of salivary α-Amylase concentrations 
(Keeshin et al. 2015).  In another study, salivary α-Amylase diurnal profiles between 
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Bosnian War refugees with PTSD and a healthy control group were compared.  The 
profile of salivary α-Amylase was the opposite between the group of subjects with PTSD 
and the healthy controls as there was an increase level of enzyme in PTSD patients and a 
decrease for the healthy controls (Thoma et al. 2012).  This may suggest that these two 
psychopathologies, PTSD and grief share the same common stress response.  The 
underlying cause for the stress response can be further investigated.   
Everyone will experience the loss of a loved one.  This was an intriguing study 
because, surprisingly, this was the first time that stress reactivity was examined during 
the discussion of the loss of a spouse.  It would be interesting to determine whether 
thinking about the loss will also lead to the same reactivity as discussing the loss.  
Normally grief does not need clinical intervention as most bereaved individuals are 
resilient and do not need mental health treatment.  However, knowledge about improved 
treatment options for those in who experience a more severe and chronic form of grief is 
crucial to help reduce the pain and agony that these grieving individuals suffer from such 
as dysfunctional thoughts, maladaptive behaviors and emotion dysregulation.  The stress 
caused by bereavement can also lead to or worsen other physical or mental disorders such 
as depression, panic disorder, post-traumatic stress disorder, greater suicidality and sleep 
disorders.   
This paper describes the rationale and methods of evaluating stress and grief 
symptoms in recently bereaved elders and there may be some evidence that grief is 
correlated with stress reactivity.  The findings of this study are expected to be relevant for 
future studies targeting loss-related sympathetic reactivity, which might be an interesting 
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avenue to decrease grief related distress and impairment including impairment in work 
and social function, sleep disturbance, disruption in daily activities, suicidal thinking and 
behavior, substance abuse, and impairment in relationship functioning.  Currently, there 
are programs that aim to reduce stress through psychotherapy such as the Stress 
Management and Resiliency Training(SMART)-Relaxation Response Resiliency 
Program(3RP) designed at Massachusetts General Hospital Benson-Henry Institute for 
Mind Body Medicine.  The Relaxation Response Resiliency Program (3RP) is a 
comprehensive, multimodal treatment designed to promote adaptation to stress and 
enhance resiliency (Park et al. 2013).  Research on Relaxation Response interventions 
have suggested that it is effective in reducing hypertension, insomnia, anxiety, pain and 
medication use for a variety of conditions (Mandle et al. 1996).  Future research 
examining sympathetic activity in grief and its relationship with persistent complex 
bereavement disorder pathophysiology is warranted.   
Strengths of this study include (1) a diverse group of qualified subjects, (2) 
assessment of eligibility not only by self-report questionnaires but also by a clinical 
interview with a psychiatrist, (3) specifically designed and validated Kinetic Enzyme 
Assay Kit to measure α-Amylase concentrations.  Limitations for this study include (1) a 
small sample size as there were only 8 subjects, (2) inability to collect select saliva 
samples, (3) saliva samples obtained at different times during the day for different 
subjects, (4) absence of a real control condition.  The closest condition to a control 
condition for this study is the duration between Sample 3 and Sample 4 while subjects are 
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discussing information that does not pertain to the loss.  The α-Amylase concentration 
decreases back to around baseline level during this time.   
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